Results 151 to 160 of about 56,832 (260)

Synergistic Enhancement of Antioxidant Activity in Arbutus unedo Leaf Extract by Biological Fluids: Implications for Functional and Nutraceutical Applications

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT This study examined the effect of biological fluids (saliva, blood plasma, and urine) on the antioxidant capacity of an aqueous extract derived from Arbutus unedo leaves. The extract displayed a concentration‐dependent reducing activity in the ferric reducing power assay (IC50 = 292 ± 7.54 µg/mL) and phosphomolybdenum assays (IC50 = 461.67 ± 4.
Idir Moualek   +6 more
wiley   +1 more source

One‐Step Electrodeposition of Iron Oxyhydroxide Onto 3D Porous Graphene Substrates for on Chip Asymmetric Micro‐Supercapacitors

open access: yesBatteries &Supercaps, Volume 8, Issue 3, March 2025.
A micro‐supercapacitor with electrodeposited iron oxyhydroxide (FeOOH) as the negative electrode and birnessite manganese oxide (MnO2) as the positive electrode achieves a 2 V working voltage, stable cycling in an aqueous electrolyte, and high energy and power densities of 21 μWh cm‐2 and 2.5 mW cm‐2 respectively.
Filipe Braga   +6 more
wiley   +1 more source

The Interaction Between Ferric Nucleotide Coordination Compounds and Transferrin

open access: yesChinese Journal of Applied Chemistry, 1996
Jipo Wang, Hui Zhao, Yianzheng Sun
openaire   +1 more source

Liquid‐phase oxidation of furfural catalyzed by magnetically separable metal oxide nanoparticles deposited on silica gel

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Oxidation of furfural (FF), a bio‐based platform chemical, was investigated using a range of iron‐, vanadium‐ and iron–zinc‐oxalates supported on silica gel (FeVOx@silica and FeZnOx@silica, respectively) as precursor for FeV@silica and FeZn@silica oxide catalysts and H2O2 as a green oxidant.
Alexander Pokutsa   +2 more
wiley   +1 more source

Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz   +7 more
wiley   +1 more source

N‐acetylcysteine for non‐paracetamol‐induced acute liver failure in children: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Non‐surgical treatment of acute liver failure (ALF) is primarily supportive and depends on the underlying cause. While N‐acetylcysteine (NAC) is proven effective in paracetamol‐induced ALF, its potential benefits in non‐paracetamol ALF for paediatric patients remain unclear.
Alise D. E. de Groot   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy